HOME | FRANÇAIS

HIGHLIGHTS

PHOTOS

2016 CAN-PAT SURVEY
>> Results from 2015

PROGRAM
>> At a glance
>> Guest speakers
>> Symposium speakers
>> Case submission

CREDITS AND EVALUATION

TRAVEL

ACCOMMODATION

SOCIAL EVENTS

WINTER ACTIVITIES

PAST AND FUTURE MEETINGS

PLANNING COMMITTEE

CONTACT US

Program outline

FULL PROGRAM (PDF)

Thursday | Friday | Saturday | Sunday

2016 CRS meeting learning objectives

At the end of this meeting, participants will be able to:

  • Describe present and future uses of optical coherence tomography
  • Identify the technological and technique-based advances in Vitreoretinal surgery
  • Describe the imaging features and therapeutic options for macular disease(s)
  • Identify the evolving trends and practices of Canadian Retina Specialists in the management of retinal disease(s)
Thursday, March 3 2016
1200-1500Arrivals
1620-1725

Scientific session 1 - Medical Retina Case Conference

At the end of this session, participants will be able to:

  • Expand their differential diagnosis for medical retinal conditions
  • Identify uncommon retinal diseases
  • Enhance their management of retinal diseases

1620Welcome · Jim Whelan, MD and Netan Choudhry, MD
1625Mystery cases · Panelists: Deepa Yoganathan, MD (moderator), K. Bailey Freund, MD, Netan Choudhry, MD, Jim Whelan, MD
  • Mystery Case 1: Amelanotic choroidal mass · Alice Yang Zhang
  • Mystery Case 2: Black spot in the left eye · Alice Yang Zhang
  • Mystery Case 3: Dark knight disease? · Rishi Gupta
  • Mystery Case 4: Inner and outer retinal changes in a case of Alport syndrome · Rayan Alshareef
  • Mystery Case 5: Simultaneous central retinal artery occlusion and optic Nerve Vasculitis in Crohn's Disease · Razek Georges Coussa
  • Mystery Case 6: On wide field F/A and anti-VEGF · Marie Carole Boucher
  • Mystery Case 7: Is it AMD? · Errol Chan
  • Mystery Case 8: A progressive pigmentary retinopathy · David Maberley
1725Adjourn
1730-1900CRS Annual General Meeting
1900-2000Welcome reception
Friday, March 4, 2016
0600-0630Breakfast
0630-0855

Scientific session 2 - Retinal Imaging I

At the end of this session, participants will be able to:

  • Identify recent changes to our understanding of OCT-based retinal anatomy
  • Indicate key imaging features of age-related macular degeneration subtypes
  • Become familiar with newer microbes implicated in culture-negative endophthalmitis

0630Welcome and introductions · Netan Choudhry, MD
0635Evolving understanding of ocular anatomy and disease with OCT · Alex Walsh, MD
0655Q & A
0705Imaging neovascular subtypes in AMD · K. Bailey Freund, MD
0725Q & A
0735What intravitreal injections have taught us about endophthalmitis/First person recording of retinal procedures · Sunir Garg, MD
0755Panel discussion · Netan Choudhry, MD (moderator), Sunir Garg, MD, Alex Walsh, MD, K. Bailey Freund, MD
0805Anti-VEGF switch and adverse event cases (includes Q & A) · Panelists: Deepa Yoganathan, MD (moderator), K. Bailey Freund, MD, Rishi Gupta, MD
  • Anti-VEGF Switch Case 1: A tale of two switches · Nilesh Persad
  • Anti-VEGF Switch Case 2: Switching from ranibizumab to aflibercept showed early remarkable visual and morphologic outcome in a case with wet age-related macular degeneration · Aissa Iggui
  • Adverse Event Case 1: Infectious necrotizing scleritis after intravitreal ranibizumab injection · Razek Georges Coussa
  • Adverse Event Case 2: Is there a relationship between anti-VEGF therapy and cranial nerve palsy? · Nilesh Persad
  • Adverse Event Case 3: Where did that hole come from? · Deepa Yoganathan
0855Adjourn
0855-0910Refreshment break
0910-1010

Co-developed symposium: wARMD 360° - Evolution of Disease Management
SEE POSTER

Planning Committee: Chair/CRS representative: Netan Choudhry, MD, Members: Rishi Gupta, MD, David E. Lederer, MD
Faculty: Netan Choudhry, MD, Joan W. Miller, MD, Rishi Gupta, MD, K. Bailey Freund, MD, David E. Lederer, MD

At the end of this session, participants will be able to:

  • Describe the evolution of treatments for exudative ARMD
  • Discuss the current evidence for switching agents in the treatment of wet ARMD and non-responders
  • Assess the evidence regarding a possible association between intravitreal anti-VEGF therapy and macular atrophy in neovascular ARMD
  • Identify the evolving role of OCT-angiography in the management of neovascular ARMD

0910Welcome and introductions · Netan Choudhry, MD
0915A brief history of the management of neovascular ARMD · Rishi Gupta, MD
0925Switching agents: when, how, why? · Joan W. Miller, MD
0935Geographic atrophy in the anti-VEGF era · K. Bailey Freund, MD
0945New frontiers in retinal imaging: OCT-angiography for wet ARMD · Netan Choudhry, MD
0955Panel discussion · Moderators: Netan Choudhry, MD, David E. Lederer, MD
Faculty: K. Bailey Freund, MD, Rishi Gupta, MD, Joan W. Miller, MD

This session was co-developed by the Canadian Retina Society, the Canadian Ophthalmological Society and Bayer and was planned to achieve scientific integrity, objectivity and balance


1010Adjourn
1530-1600Refreshment break
1600-1830

Scientific session 3 - Retinal Imaging II

At the end of this session, participants will be able to:

  • Discuss future developments in optical coherence tomography
  • Describe the current research in retinal anatomy using optical coherence tomography
  • Assess the role of the choroid within the pachychoroid spectrum
  • Identify imaging features of White Dot Syndromes

1600Introduction · Jim Whelan, MD
1605New frontiers in OCT · Alex Walsh, MD
1625Q & A
1635New multi-modal imaging findings in white dot syndromes · K. Bailey Freund, MD
1655Q & A
1705Automated multi-functional OCT · Alex Walsh, MD
1725Q & A
1735The pachychoroid spectrum - K. Bailey Freund, MD
1800Panel discussion · Jim Whelan, MD (moderator), Alex Walsh, MD, K. Bailey Freund, MD, David Maberley, MD
1830Adjourn
1900-2200A Night at the Sugar Shack, Reception-style dinner (off site)
Saturday, March 5, 2016
0600-0630Breakfast
0630-0855

Scientific session 4 - Vitreoretinal Surgery

At the end of this session, participants will be able to:

  • Discuss the challenges in retinal detachment surgery & role of ILM peeling
  • Demonstrate the utility of 27-gauge vitrectomy in vitreoretinal surgery
  • Describe the real-world utility of ocriplasmin in symptomatic vitreomacular adhesion (sVMA)
  • Identify novel methods of IOL rescue and secondary IOL placement

0630Welcome and introductions · Jim Whelan, MD
0635Retinal detachment: a primer · Gaurav Shah, MD
0700Q & A
071027-gauge surgery: applications and limitations · Gaurav Shah, MD
0735Q & A
0745Clinical reality of ocriplasmin use and outcomes · Gaurav Shah, MD
0810Q & A
0820Secondary intraocular lenses · Sunir Garg, MD
0845Panel discussion · Jim Whelan, MD (moderator), Gaurav Shah, MD, Sunir Garg, MD, Flavio Rezende, MD
0855Adjourn
0855-0910Refreshment break
0910-1010

Co-developed symposium - Advanced VR Course: Do you know your vitrectomy machine? Things you want to know.
SEE POSTER

Planning Committee: Chair: Wai-Ching Lam, MD, CRS Representative: Jim Whelan, MD, Member: Michael Kapusta, MD
Faculty: Wai-Ching Lam, MD, Jim Whelan, MD, Michael Kapusta, MD, David Chow, MD, Hugh Parsons, MD

At the end of this session, participants will be able to:

  • Describe principles and physiological rational of the various vitrectomy parameters
  • Identify the advanced settings of the vitrectomy machine
  • Apply the new knowledge of the vitrectomy to achieve better patient surgical outcome

0910Welcome and introductions · Wai-Ching Lam, MD
0915VGFI, flow limit, IOP control.... Do you know what all this means? · Michael Kapusta, MD
0925Advanced settings of the vitrectomy machine: it’s time to find out what they are · David Chow, MD
0935The development of vitreo-retinal surgery – past, present and future · Hugh Parsons, MD
0945Panel discussion · Moderator: Wai-Ching Lam, MD
Faculty: David Chow, MD, Michael Kapusta, MD, Hugh Parsons, MD

This session was co-developed by the Canadian Retina Society, the Canadian Ophthalmological Society, and Alcon to achieve scientific integrity, objectivity, and balance.


1010Adjourn
1530-1600Refreshment break
1600-1745

Scientific session 5 - Vision Rehabilitation & Therapeutics

At the end of this session, participants will be able to:

  • Determine the retina specialist's role in vision rehabilitation
  • Identify emerging therapies for dry age-related macular degeneration

1600Introductions · Netan Choudhry, MD, with remarks by John Galic, MD, President of the Retina Foundation of Canada
1605Dr. Mila Oh Memorial Lecture: Vision rehabilitation for the patient receiving intravitreal injections · Mary Lou Jackson, MD
1650Q & A
1700Emerging therapies for dry AMD · Sunir Garg, MD
1720Panel discussion · Jim Whelan, MD (moderator), Sunir Garg, MD
1735Foundation Fighting Blindness · Remarks by Dr. Mary Sunderland, Director of Research & Education
1745Adjourn
1900-2000Ice Bar Reception
Sunday, March 6, 2016
0630-0700Breakfast
0700-1000

Scientific session 6 - Canadian Retina Practice Perspectives

At the end of this session, participants will be able to:

  • Identify the trends in Anti-VEGF management of retinal disease in Canada
  • Describe the surgical preferences and practices of Canadian vitreoretinal surgeons
  • Discuss the socioeconomic variability in retinal practices and coverage across Canada

0700 Introduction · Jim Whelan, MD
0705Expanding the dialogue: results of the Canadian Preferences and Trends (CAN-PAT) Survey · Netan Choudhry, MD, Jim Whelan, MD
0735Q & A
0805Challenging surgical cases · Panelists: Deepa Yoganathan, MD (moderator), Michael Kapusta, MD, Amin Kherani, MD
  • Surgical Case 1: The use of the pericardial patch in retinal surgery · Hugh Parsons
  • Surgical Case 2: Clinical presentation, management and outcome of two perforating globe injuries · Amin Kherani
  • Surgical Case 3: Subretinal perfluorocarbon liquid · Alice Yang Zhang
  • Surgical Case 4: A web of mystery · Cynthia Qian
  • Surgical Case 5: The unrelenting detachment · Mikel Mikhail
  • Surgical Case 6: Triamcinolone acetonide used to prevent IFCG toxicity during an inverted flap chromo surgery for large FTMH · Aissa Iggui
  • Surgical Case 7: Extreme post-op complication · Peng Yan
  • Surgical Case 8: Management of giant retinal tear detachment · Michael Dollin
  • Surgical Case 9: Working toward a cell-based therapy for geographic atrophy · Peter Kertes
  • Mystery Case 9: The clue was in the past medical history · Julie Vadboncoeur
  • Mystery Case 10: Postoperative hemorrhagic occlusive retinal vasculitis · Ananda Kalevar
  • Mystery Case 11: Pigmentary retinal degeneration · Marina Gilca
1000Adjourn